Design of SERENA-6, a phase III switching trial of camizestrant in
ESR1
-mutant breast cancer during first-line treatment
Published Online: 2023-03-?
Journal: Future OncologyLoading...
Authors: Cynthia Huang-Bartlett•Cynthia X Ma•Erica L Mayer•Francois-Clement Bidard•Giampaolo Bianchini•Hiroji Iwata•Kevin Kalinsky•Massimo Cristofanilli•Nicholas Turner•Sasha McClain•Stephen Chia•Steven Fox•Wolfgang Janni•Xiaochun Liu•Yeon Hee Park
